Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-7,427
Closed -$417K 526
2016
Q4
$417K Buy
7,427
+2,748
+59% +$161K 0.06% 227
2016
Q3
$279K Buy
+4,679
New +$274K 0.04% 377
2014
Q2
Sell
-16,358
Closed -$886K 211
2014
Q1
$886K Buy
16,358
+12,348
+308% +$639K 0.21% 61
2013
Q4
$191K Buy
+4,010
New +$183K 0.05% 178

Other funds holding MRK

Parkwood LLC's MRK Position: Q1 2017 in Review

Parkwood LLC sold out of Merck (MRK) in Q1 2017, closing a stake of 7,427 shares — an estimated $417K sold.

Parkwood LLC first reported a position in MRK in Q4 2013 and held it in 4 quarters. The position peaked at $886K in Q1 2014. 1,941 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

  • Parkwood LLC reported no remaining Merck position as of Q1 2017 after selling out during the quarter.
  • Parkwood LLC sold 7,427 Merck shares in Q1 2017, an estimated $417K.
  • Parkwood LLC first reported a position in Merck in Q4 2013 and held it in 4 quarters.
  • Parkwood LLC's Merck position peaked at $886K in Q1 2014.
  • 1,941 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on Parkwood LLC's 13F filing for Q1 2017, filed 5 May 2017.